BioSig Technologies, Inc. (STEX)
NASDAQ · Financial Services
BioSig Technologies, Inc. Income Statement 2020–2024
| Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|
| Revenues | |||||
| Revenue | 40,000 | 18,000 | 286,000 | 441,000 | 0 |
| Gross Profit | — | 18,000 | 229,000 | 242,000 | 0 |
| Profitability | |||||
| Operating Income | -12.9M | -28.5M | -27.3M | -33.4M | -59.2M |
| EBITDA | -12.7M | -28.2M | -27.0M | -33.2M | -59.1M |
| Net Income | -10.3M | -29.0M | -27.1M | -31.9M | -52.2M |
| Per Share Data | |||||
| EPS (diluted) | — | — | — | — | — |
| Shares Outstanding (dil.) | 14M | 7M | 4M | 36M | 31M |
BioSig Technologies, Inc. Income Statement — FAQ
BioSig Technologies, Inc. (STEX) income statement over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see STEX's income statement history?
The chart and table above show BioSig Technologies, Inc.'s income statement by year and by quarter, including the growth rate.